FDA Suspends Drug Safety

News

Sarepta, FDA and Gene Therapy

FDA weighs new study requirements for Sarepta to confirm safety of gene therapy Elevidys: report

Sarepta would need to conduct new analyses to validate the safety of Elevidys—which has had U.S. shipments paused by the company over a mounting string of controversies—to the FDA, Endpoints News and Bloomberg separately reported Thursday, citing an unnamed senior FDA official.

InvestorsHub on MSN · 6d

Sarepta Shares Drop as FDA Suspends Gene Therapy Trials for Muscular Dystrophy

· 8d

Sarepta Refused FDA’s Request to Halt Elevidys Shipments

6don MSN

FDA Suspends Muscular Dystrophy Drug After 3 Patient Deaths

The U.S. Food and Drug Administration ( FDA) has placed an immediate clinical hold on Sarepta Therapeutics' investigational ...

BioSpace5d

Sarepta Concedes to FDA Request, Suspends US Shipments of Elevidys

After initially refusing to suspend Elevidys distribution after two deaths, Sarepta has now given in to the FDA’s request, ...

Sarepta Stock Keeps Sliding as Company Rejects FDA Call to Withdraw Drug

Sarepta Therapeutics has rejected a call by the Food and Drug Administration to stop shipments of its muscular dystrophy drug ...

6don MSN

FDA names former pharmaceutical company executive to oversee US drug program

FDA Commissioner Marty Makary announced that Dr. George Tidmarsh, a cancer and pediatric specialist, will direct the agency’s ...

13don MSN

FDA suspends Cafe Goodluck’s licence over lack of hygiene

Pune: The Maharashtra Food and Drug Administration (FDA) has issued a notice of licence suspension to Cafe Goodluck on FC ...

Naija Gist - Latest11mon

FDA Suspends Most Safety Inspections of Food - Pulse Nigeria

WASHINGTON — The Food and Drug Administration has stopped routine food safety inspections of seafood, ... FDA Suspends Most Safety Inspections of Food 09 August 2024 at 23:20 ...

Some results have been hidden because they may be inaccessible to you

Show inaccessible results